Hypercalcemia: a consultant's approach.

Hypercalcemia remains a complex clinical issue in pediatric patients. Nephrologists frequently encounter this condition due to their focus on mineral balance. The presence of acute kidney injury or renal calcifications adds diagnostic challenges. Prior research has shown that hypercalcemia can stem from various causes, including genetic and acquired factors. Serum calcium levels alone may not fully reflect the condition's severity. Albumin-adjusted total calcium is a common alternative when ionized calcium is unavailable. The role of parathyroid hormone and vitamin D metabolites in diagnosis is well established. This paper fills a gap by offering a consultant's approach to assessing and managing pediatric hypercalcemia.

This review aims to guide clinicians in evaluating and treating hypercalcemia in children. The focus is on nephrology consultations, especially in cases involving kidney injury. The study addresses the need for a structured approach to diagnosis and management. It emphasizes the importance of ionized calcium measurement for accurate severity assessment. The paper highlights the role of parathyroid hormone and vitamin D metabolites in identifying causes. It also considers the value of albumin-adjusted calcium in resource-limited settings. The goal is to provide a practical framework for differential diagnosis. The review covers both acute and long-term treatment strategies.

The authors use a review approach to synthesize existing knowledge on pediatric hypercalcemia. They analyze the pathophysiology of mineral imbalances and their clinical implications. The paper outlines a step-by-step diagnostic process for identifying causes. It discusses the use of laboratory tests, including parathyroid hormone and vitamin D metabolites. The review evaluates available treatment options for acute hypercalcemia. It considers the role of fluids, loop diuretics, and antiresorptive agents. The authors integrate both genetic and acquired etiologies into the discussion. They provide a structured framework for managing cases with kidney involvement.

The review identifies plasma ionized calcium as the most accurate measure of hypercalcemia severity. When unavailable, albumin-adjusted total calcium is a reliable alternative. Serum parathyroid hormone levels are key in differentiating between primary and secondary causes. Vitamin D metabolite testing helps identify acquired or genetic factors. Fluids and loop diuretics are central to acute treatment strategies. Antiresorptive agents are used to reduce calcium release from bone. The paper emphasizes the importance of early diagnosis in preventing renal complications. It outlines a systematic approach to managing hypercalcemia in pediatric nephrology.

The authors propose that ionized calcium measurement is essential for accurate hypercalcemia assessment. They suggest using albumin-adjusted total calcium in its absence. The review highlights the diagnostic value of parathyroid hormone and vitamin D metabolites. It supports the use of fluids and loop diuretics in acute treatment. Antiresorptive agents are recommended for long-term management. The paper emphasizes the need for a structured approach in pediatric nephrology. It suggests that early diagnosis can prevent complications like kidney injury. The authors conclude that a consultant's approach improves clinical outcomes.